Related Experiment Video

Updated: May 22, 2026

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells
08:03

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells

Published on: October 20, 2015

[Circulating tumor cells and advanced prostate cancer]

Thibaut Murez1, Stéphane Droupy, Xavier Rebillard

  • 1CHU, service d'urologie-andrologie, place du Professeur-Robert-Debré, 30029 Nîmes Cedex 9, France. thibaut.murez@gmail.com

Bulletin Du Cancer
|May 10, 2012
PubMed
Summary

Circulating tumor cells show promise as prostate cancer biomarkers, but current detection methods require further development for reliable clinical use. Improved cellular characterization is key to predicting metastasis potential.

More Related Videos

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications14:14

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment05:17

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Published on: May 14, 2019

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...